FR
12 March 2017 Compliance

SEC investigations in the Pharmaceutical industry in China

Leaf has represented a pharmaceutical company in an investigation made by the US Department of Justice and the Securities and Exchange Commission on distribution practices in China. Negotiation with Chinese authorities regarding the same facts.

On this subject.

12 June 2023
Acquisition in Automotive Components
6 June 2023
Strategic Cooperation in Energy Industry
1 June 2023
Strategic Acquisition in Investment Banking
30 May 2023
Joint Venture for Retail Expansion
10 May 2023
Acquisition of a leading qualitative research agency with offices in Europe and China
2 November 2022
Strategic Partnership in Medical Devices
7 June 2022
Acquisition of Creative Agency in China
12 April 2022
Strategic Joint Venture: Clinical Research Collaboration
21 December 2021
Strategic Investment: Event Company acquires Chinese Seed Expo
26 July 2021
Strategic Investment: Event Company Joins Convention Group
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.